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The adrenal cortex is divided into concentric zones. In humans the major cortical zones are
the zona glomerulosa, zona fasciculata, and zona reticularis.The adrenal cortex is a dynamic
organ in which senescent cells are replaced by newly differentiated ones. This constant
renewal facilitates organ remodeling in response to physiological demand for steroids.
Cortical zones can reversibly expand, contract, or alter their biochemical profiles to accom-
modate needs. Pools of stem/progenitor cells in the adrenal capsule, subcapsular region,
and juxtamedullary region can differentiate to repopulate or expand zones. Some of these
pools appear to be activated only during specific developmental windows or in response
to extreme physiological demand. Senescent cells can also be replenished through direct
lineage conversion; for example, cells in the zona glomerulosa can transform into cells
of the zona fasciculata. Adrenocortical cell differentiation, renewal, and function are regu-
lated by a variety of endocrine/paracrine factors including adrenocorticotropin, angiotensin
II, insulin-related growth hormones, luteinizing hormone, activin, and inhibin. Additionally,
zonation and regeneration of the adrenal cortex are controlled by developmental signaling
pathways, such as the sonic hedgehog, delta-like homolog 1, fibroblast growth factor, and
WNT/β-catenin pathways.The mechanisms involved in adrenocortical remodeling are com-
plex and redundant so as to fulfill the offsetting goals of organ homeostasis and stress
adaptation.
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INTRODUCTION
The adrenal cortex is a major source of steroid hormones, which
are synthesized from cholesterol through the sequential actions
of a series of cytochrome P450 (CYP) enzymes and hydroxys-
teroid dehydrogenases (HSDs) (Figure 1) (1). Anatomically and
functionally distinct zones in the adrenal cortex synthesize spe-
cific steroid hormones in response to endocrine and paracrine
signals. The regulation of adrenocortical development and home-
ostasis has been the subject of intensive investigation over the
past decade (2–4). This review article summarizes recent advances
in our understanding of adrenocortical zonation, renewal, and
remodeling. Animal models useful for studies of adrenocortical
biology, such as the mouse, rat, and ferret, are highlighted.
ADRENOCORTICAL ZONATION IN HUMANS AND ANIMAL
MODELS
The adrenal cortex of humans is composed of three concentric
layers: the zona glomerulosa (zG), zona fasciculata (zF), and zona
reticularis (zR) [reviewed in Ref. (2)]. The outermost layer, the
zG, functions as part of the renin-angiotensin-aldosterone sys-
tem (RAAS). In response to angiotensin II (Ang II) or elevated
plasma potassium ion (K+) concentrations, zG cells secrete aldos-
terone, a mineralocorticoid that induces the retention of sodium
ion (Na+) and water and the excretion of K+ by the kidney. Cells
in the zG express the Ang II receptor (AT1R) and aldosterone
synthase (CYP11B2). At the ultrastructural level, zG cells are typi-
fied by numerous mitochondria with lamelliform cristae and a few
cytoplasmic lipid droplets (Figure 2A). Cells in the zF produce glu-
cocorticoids as part of the hypothalamic-pituitary-adrenal (HPA)
axis. zF cells respond to adrenocorticotropic hormone (ACTH)
via its receptor (MC2R) and the accessory protein MRAP. Cells
in the zF are organized in cord-like structures, or fascicles, that
are surrounded by fenestrated capillaries. Cells in this zone con-
tain numerous mitochondria with tubulovesicular cristae, many
cytoplasmic lipid droplets, and prominent smooth endoplasmic
reticulum (Figure 2B) (5, 6). The innermost layer of the cortex, the
zR, secretes the weak androgen dehydroepiandrosterone (DHEA)
and its sulfated form DHEA-S (1). Cells of the zR resemble those
of the zF but contain fewer lipid droplets and more lysosomes
and vacuoles (6). The adrenal gland is covered by a fibrous cap-
sule that serves as both a support structure and a reservoir of
stem/progenitor cells for the cortex (see Section “Adrenocortical
Stem Cells”) (7).
Species differ in their adrenocortical zonation patterns (8)
(Figure 3). In the mouse and rat, the adrenal cortex contains zG
and zF, but there is no recognizable zR. The adrenal cortex of the
young mouse contains an additional, ephemeral layer known as
the X-zone (9, 10). The function of the X-zone remains controver-
sial, but it may be involved in progesterone catabolism (11). The
rat adrenal cortex contains a less prominent layer, the undifferen-
tiated zone (zU), located between the zG and zF (12). The zU has
been implicated in adrenocortical homeostasis and remodeling
(see Section “Delta-like Homologue 1 Pathway”) (12, 13). Cells in
the inner aspect of the zU express MC2R and cholesterol side-chain
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FIGURE 1 | Steroidogenic pathways in the human adrenal cortex and gonads.
FIGURE 2 | Electron microscopy of mouse adrenal cortex. Adrenal
glands from a 4-month-old female mouse were fixed in Karnovsky’s
solution, postfixed in 2% OsO4, dehydrated, and then embedded in epon.
Thin sections were stained with uranyl acetate plus lead citrate and
examined by transmission electron microscopy. (A) Adrenal capsule and
zona glomerulosa. (B) Zona fasciculata. Abbreviations: c, capsule; e,
endothelial cell; zF, zona fasciculata cell; zG, zona glomerulosa cell.
Bars, 4µm.
cleavage enzyme (CYP11A1), which catalyzes the first reaction
in steroidogenesis. The inner zU lacks expression of markers of
the zG (Cyp11b2) or zF (steroid 11β-hydroxylase; Cyp11b1) (14).
Thus, the inner zU may represent a transitional population of cells
committed to the steroidogenic phenotype. An analogous layer,
the zona intermedia (zI), is present in the adrenal glands of fer-
rets (15). Recently, the spiny mouse (genus Acomys) has attracted
attention as a novel model for the study of adrenocortical devel-
opment and function. In contrast to the laboratory mouse (genus
Mus), the adrenal cortex of the spiny mouse contains the zR and
secretes both cortisol and DHEA (16). In this respect the adrenal
gland of the spiny mouse mimics that of humans.
Species also vary in the repertoire of steroidogenic enzymes
and cofactors expressed in the adrenal cortex, and these differ-
ences impact function (Figure 3). Two factors that are differen-
tially expressed among species are 17α-hydroxylase/17,20 lyase
(CYP17A1) and cytochrome b5 (CYB5). CYP17A1, a bifunc-
tional enzyme, catalyzes the 17α-hydroxylation reaction required
for cortisol synthesis and the 17,20-lyase reaction required for
the androgen production (1). The lyase activity is enhanced by
allosteric interactions with CYB5 (1). Cells in the zF and zR
of humans and ferrets have 17α-hydroxylase activity, so cortisol
is the principal glucocorticoid secreted by the adrenal gland of
these organisms (8). In humans the adrenal cortex begins to pro-
duce DHEA and DHEA-S at adrenarche, contemporaneous with
increased expression of CYB5 in the zR (1). The adrenal glands
of ferrets produce only limited amounts of androgens due to low
CYB5 expression (8, 17). Cells in the adrenal cortex of adult mice
and rats lack CYP17A1, so corticosterone is the principal gluco-
corticoid secreted, and adrenal androgens are not produced (8).
The relative strengths and weaknesses of established and emerging
animal models are summarized in Table 1.
ADRENOCORTICAL RENEWAL AND REMODELING
The adult adrenal cortex is a dynamic tissue. Cells lost through
senescence or injury are continually replenished through cell
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FIGURE 3 | Comparative anatomy and physiology of the adrenal cortex.
The undifferentiated zone of the rat adrenal is subdivided into outer (dark gray)
and inner (light gray) zones that differ in marker expression and function (see
the text). Abbreviations: cap, capsule; med, medulla; X, X-zone; zF, zona
fasciculata; zG, zona glomerulosa; zI, zona intermedia; zR, zona reticularis; zU,
undifferentiated zone.
Table 1 | Advantages and disadvantages of various animal models for studies of adrenocortical zonation and remodeling.
Mouse Rat Spiny mouse Ferret
Advantages • Genetically and epigenetically
tractable
• Well suited for transplantation
experiments
• Gonadectomy triggers the
accumulation of gonadal-like
cells in the adrenal cortex (see
Section “LH Signaling”)
• Well suited for
pharmacological studies (see
Section “Adrenocortical
Renewal and Remodeling”)
• Adrenal enucleation
experiments are feasible (see
Section “Adrenocortical
Renewal and Remodeling”)
• Adrenal gland is
anatomically and
functionally similar to that
of humans
• Well characterized
neuroendocrine physiology
• Gonadectomy triggers the
accumulation of
gonadal-like cells in the
adrenal cortex (see Section
“LH Signaling”)
Disadvantages • Lacks zR and does not
produce androgens
• Lacks zR and does not
produce androgens
• Not widely available
• Not standardized with
regard to genotype
• Not standardized with
regard to genotype
division and differentiation (2, 4). In the adult adrenal gland,
most cell proliferation occurs near the periphery of the cor-
tex, as shown by bromodeoxyuridine and [3H]thymidine labeling
experiments [reviewed in Ref. (3)]. The remarkable regenerative
capacity of the organ is evidenced by rat adrenal enucleation exper-
iments, wherein the gland is incised and squeezed so as to extrude
the cortex. Within weeks a new adrenal cortex regenerates from
the remaining capsule and adherent subcapsular cells [reviewed
in Ref. (18)].
Constant cellular turnover in the adrenal cortex facilitates
rapid organ remodeling in response to physiological demand
for steroids. Zones can reversibly enlarge, shrink, or alter their
biochemical profiles to accommodate physiological needs or in
response to experimental manipulations (Table 2). For example,
administration of captopril, an inhibitor of the RAAS, leads to
contraction of the zG in rats [reviewed in Ref. (2)].
OVERVIEW OF ADRENOCORTICAL DEVELOPMENT
Embryogenesis and early postnatal development provide a con-
textual framework for understanding the mechanisms involved
in adrenocortical zonation and homeostasis. Although struc-
turally and functionally distinct, the adrenal cortex, ovary, and
testis arise from a common progenitor, the adrenocortical pri-
mordium (AGP). The AGP is derived from a specialized region
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Table 2 |Triggers of zonal remodeling in the adrenal cortex.
Zone (species) Physiological or
experimental
trigger
Effect Reference
zG (rat) ↓ [Na+] or ↑ [K+]
in diet
Expands the zone,
increasing aldosterone
production
(2)
↑ [Na+] or ↓[K+]
in diet
Contracts the zone,
decreasing aldosterone
production
zF (rat) ACTH Expands the zone,
increasing
glucocorticoid
production
(2)
Dexamethasone Contracts the zone,
decreasing
glucocorticoid
production
zR (primates) Adrenarche in
humans and
chimpanzees
Increases the
expression of CYB5,
enhancing DHEA
production
(19)
Social status in
marmosets
Adult females develop
a functional zR in a
reversible manner
dependent on social
status
(20)
Cortisol in human
adrenocortical
cells
Stimulates DHEA
production through
competitive inhibition
of 3βHSD2 activity
(21)
X-zone (mouse) Puberty in males
or first pregnancy
in females
Induces regression of
the zone
(22)
Activin Induces regression of
the zone
(23)
Gonadectomy Delays regression of
the zone or induces
growth of a secondary
zone
(22, 23)
of celomic epithelium known as the urogenital ridge (Figure 4),
which also gives rise to the kidney and progenitors of definitive
hematopoiesis. Cells in the AGP co-express the transcription fac-
tor genes Wilms tumor suppressor-1 (Wt1), GATA-binding protein
4 (Gata4), and steroidogenic factor-1 (Sf1, also called AdBP4 or
Nr5a1) [reviewed in Ref. (2, 24, 25)]. As development proceeds,
progenitors of the adrenal cortex and the gonad separate and acti-
vate different transcriptional programs. Adrenal progenitor cells
in the AGP migrate dorsomedially into subjacent mesenchyme,
upregulate expression of Sf1, and downregulate expression of Wt1
and Gata4 (25, 26). In contrast, gonadal progenitor cells in the
FIGURE 4 | Development of the adrenal gland and gonads.
AGP migrate dorsolaterally and maintain expression of Sf1, Wt1,
and Gata4. Adrenal precursors combine with neural-crest derived
sympathoblasts, the precursors of chromaffin cells in the medulla,
to form the adrenal anlagen. Gonadal progenitors combine with
primordial germ cells to form the bipotential gonad. Subsequently,
the nascent adrenal glands become enveloped by capsule cells,
which are derived from both surrounding mesenchyme and fetal
adrenal cells that previously expressed Sf1 [reviewed in Ref. (27)].
In rodents, zonal patterns of steroidogenic enzyme expression
first become evident during embryonic development [reviewed
in Ref. (24)]. In mice, expression of Cyp11a1 is first detectable
in the nascent adrenal at embryonic day (E) 11.5–12.5 (26, 28),
and there is a concurrent increase in the level of endogenous
biotin (29). Expression of the zF marker Cyp11b1 begins at E13.5,
whereas expression of the zG markers Ang II receptor type 1 (At1b)
and Cyp11b2 appears in the periphery of the cortex just before
birth, and Cyp11b2 and Cyp11b1 expression domains are mutually
exclusive at this stage (30–32).
By the eighth week of gestation in humans, the fetal adrenal
cortex contains two morphologically distinct layers: an inner fetal
zone (Fz) and an outer definitive zone (Dz) (33). The Fz is thick
and contains large, eosinophilic cells, whereas the Dz is thin and
contains small, basophilic cells. Functionally, the Fz resembles the
adult zR. The Fz expresses CYP17A1 and CYB5 and produces
large amounts of DHEA and DHEA-S, which are converted by the
sequential actions of the liver and placenta into estrogens. A third
cortical zone, termed the transitional zone (Tz), becomes evident
shortly thereafter. The Tz produces cortisol, and an early burst of
cortisol production during the ninth week of gestation, coincid-
ing with a transient increase in expression of 3β-hydroxysteroid
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dehydrogenase type 2 (HSD3B2), is thought to safeguard female
sexual development by suppressing the fetal HPA axis and thereby
inhibiting adrenal androgen production (34). At birth, the adrenal
gland is almost as large as the kidney, but the size of the organ
decreases dramatically over first 2 weeks of neonatal life; the Fz
involutes via apoptosis, and there is a concomitant reduction in
adrenal androgen production (1). The mouse X-zone, a remnant
of the fetal adrenal that regresses postnatally (9), is thought to be
the analog of the human Fz. Postnatally, the human Dz differen-
tiates into the anatomically and functionally distinct zones of the
adult cortex.
ADRENOCORTICAL STEM CELLS
The adrenal cortex contains stem/progenitor cells that can divide
and differentiate to replenish senescing cells and maintain or
expand zones (Table 3) [reviewed in Ref. (4)]. In one long-
standing model of adrenal zonation, the cell migration model,
stem/progenitor cells in the periphery of the adrenal cortex
differentiate and migrate centripetally to repopulate the gland
before undergoing apoptosis in the juxtamedullary region (35).
Aspects of this model have been validated through lineage tracing
analyses (24, 30, 36), but recent studies indicate that the regu-
lation of zonation is more complex than originally appreciated
[reviewed in Ref. (13)]. It is now clear that distinct pools of
stem/progenitor cells exist in the adrenal capsule, subjacent cor-
tex, juxtamedullary region, and other sites (Table 3). Some of
these pools appear to be activated only during specific develop-
mental windows or in response to extreme physiological demand.
Under certain experimental conditions, adrenocortical zones can
be replenished by centrifugal migration (37, 38). For example,
stem/progenitor cells in the juxtamedullary region can prolif-
erate, differentiate, and centrifugally repopulate the cortex with
fetal-like cells, as is seen in gonadectomy (GDX)-induced sec-
ondary X-zone formation and in a genetic model of dysregulated
cAMP production (37, 39, 40). The mechanisms that govern
centripetal and centrifugal migration are not well understood.
Whether centrifugal migration operates under basal conditions
is unknown.
ADRENOCORTICAL CELL PLASTICITY
Cell plasticity is another mechanism for replenishing adreno-
cortical cells lost to senescence or injury. Plasticity refers to the
ability of cells to adopt an alternate functional identity in response
to cues from the hormonal milieu and cellular microenviron-
ment. One form of plasticity entails trans-differentiation, the
direct conversion of one differentiated cell into a differentiated
cell of another lineage (42). A second form of plasticity involves
de-differentiation, wherein a differentiated cell reverts to a less dif-
ferentiated cell within the same tissue lineage (42). Interconversion
of differentiated cells, either through trans- or de-differentiation,
provides an alternative to regeneration via mobilization of
stem/progenitor cells. Such functional redundancy ensures organ
homeostasis and an optimal adaptation to stress (13).
The plasticity of differentiated adrenocortical cells was ele-
gantly demonstrated in fate mapping studies by Freedman et al.
(36), who used Cyp11b2-Cre to permanently mark zG cells and
their descendants with green fluorescent protein (GFP). By tracing
the fate of GFP+ cells, the investigators showed that adrenocor-
tical zonation is orchestrated in part by direct lineage conversion
of zG cells into zF cells (Figure 5). To show that zG-to-zF con-
version participates in adrenocortical remodeling, Freedman et al.
treated adult mice with glucocorticoids to inhibit the HPA axis
(36). Glucocorticoid treatment caused contraction of the zF and
loss of GFP+ cells in this zone. Following withdrawal of exoge-
nous glucocorticoids, zG-to-zF conversion resumed and the zF
expanded. Remarkably,when conversion of zG to zF cells was abro-
gated through conditional deletion of the Sf1 gene in CYP11B2+
cells, a functional zF still formed, implying the existence of alter-
nate routes for differentiation of zF cells. These alternative sources
for zF cells remain the subject of active investigation. Collectively,
these results support a model in which differentiated cells undergo
lineage conversion during adrenocortical renewal and remodeling.
Table 3 | Stem/progenitor cell populations that give rise to steroidogenic and non-steroidogenic cells in the adrenal cortex.
Stem/progenitor
population
Location Comments Reference
WT1+ progenitors Capsule Under basal conditions, WT1+ capsule cells give rise to steroidogenic cells in the
adrenal cortex. GDX triggers their differentiation into gonadal-like tissue
(25)
GLI1+ progenitors Capsule In response to SHH, GLI1+ progenitors migrate into the cortex and differentiate into
steroidogenic cells
(27, 30, 41)
TCF21+ progenitors Capsule TCF21+ capsular cells give rise to non-steroidogenic stromal cells in the adrenal cortex (27)
SHH+ progenitors Subcapsular region These progenitors give rise to steroidogenic cells in the zF and zG but not capsule cells (27, 30, 41)
Fetal adrenal-like
progenitors
Juxtamedullary region These progenitors, normally dormant in the adult, can become activated following
certain experimental manipulations and migrate centrifugally
(37, 39, 40)
These progenitor populations, defined by fate mapping studies and related techniques, are not mutually exclusive. For example, WT1+ progenitors have been shown
to co-express Gli1 and Tcf21. Some of these progenitors give rise to differentiated cells only during specific developmental windows or in response to experimental
manipulation.
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FIGURE 5 | Adrenocortical zonation during postnatal mouse
development results from lineage conversion of zG cells into zF cells,
as evidenced by fate mapping using Cyp11b2 -cre and a GFP reporter.
Recombination of the reporter in zG leads to expression of GFP (green
cells). The resultant cells migrate inward and differentiate into zF cells.
Abbreviations: cap, capsule; med, medulla; X, X-zone; zF, zona fasciculata;
zG, zona glomerulosa.
DEVELOPMENTAL SIGNALING PATHWAYS IMPLICATED IN
ADRENOCORTICAL ZONATION, RENEWAL, OR REMODELING
Developmental signaling pathways control cell pluripotency, dif-
ferentiation, and patterning in various tissues. As detailed below,
some of these signaling pathways play key roles during the expo-
nential growth phase of adrenal cortex development (12, 24, 43,
44). Additionally, these pathways regulate renewal and remodeling
in the adult organism.
HEDGEHOG PATHWAY
The hedgehog family of morphogens comprises sonic hedgehog
(SHH), Indian hedgehog, and desert hedgehog. Each of these lig-
ands binds to Patched-1 (PTCH1), a transmembrane receptor that
is expressed on target cells (45). In the absence of hedgehog bind-
ing, PTCH1 inhibits the G protein-coupled receptor Smoothened
(SMO) [reviewed in Ref. (2, 46)]. As a result, the zinc finger tran-
scription factors GLI2 and GLI3 are proteolytically digested and
lose their activation domains (47). The resultant truncated forms
of GLI2 and GLI3 repress transcription. Binding of hedgehog lig-
ands to PTCH1 relieves the inhibition it exerts on SMO, thereby
preventing the proteolytic processing of the GLI factors. Full-
length GLI2 and GLI3 act as transcriptional activators. The related
transcriptional activator, GLI1, is not expressed in the absence of
hedgehog ligand, but is upregulated by activation of the pathway.
Consequently Gli1 expression serves as a useful marker for active
hedgehog signaling (48).
SHH, the only member of the hedgehog family produced in
the adrenal cortex, is secreted by subcapsular cells that express
Sf1 but not the terminal enzymes required for corticoid synthesis
(30, 41, 49). Capsular cells, which do not express Sf1, respond to
SHH by expressing Gli1 (Figure 6). Some of these GLI1+ capsule
FIGURE 6 | GLI1+ cells in the adrenal capsule. An adrenal gland from a
1-month-old female Gli1-lacZ mouse was whole mount stained with X-gal,
cryosectioned, and counterstained with eosin. Bar, 50µm.
cells migrate centripetally into the cortex, lose responsiveness to
SHH, and become steroidogenic, as evidenced by upregulation of
Sf1 and differentiation markers characteristic of the zG (Cyp11b2)
or zF (Cyp11b1) (Table 2). GLI1+ progenitor cells efficiently con-
tribute to steroidogenic lineages during the exponential phase of
cortical growth in embryo, fetus, and newborn mouse (30). In the
adult mouse, GLI1+ progenitors contribute to the cortex with low
efficiency, but the pathway can be activated in the adult follow-
ing experimental manipulations such as dexamethasone-induced
cortical atrophy. Conditional deletion of Shh in steroidogenic cells
of the mouse adrenal results in cortical hypoplasia and capsu-
lar thinning, but does not cause major alterations in zonation
(30, 41, 49).
DELTA-LIKE HOMOLOG 1 PATHWAY
A related signaling protein implicated in adrenocortical home-
ostasis is Delta-like homolog 1 (DLK1). This factor, also known
as preadipocyte factor-1 (PREF-1), is a transmembrane protein
related to the Notch family of signaling molecules. DLK1 was
originally identified as an important regulator of the undiffer-
entiated state in preadipocytes (50). Cleavage of the extracellular
domain of DLK1 by TNF-α converting enzyme produces a bio-
logically active soluble peptide that inhibits the differentiation
of preadipocytes into mature adipocytes (50). Subsequent stud-
ies showed that DLK1 controls the quiescence of stem/progenitor
cells in not only adipose tissue but also other tissue types, including
the adrenal cortex (12, 50).
Adrenal enucleation experiments have shown that Dlk1 expres-
sion is downregulated and not re-established until zonation of the
cortex is complete, suggesting that DLK1 is a negative regulator of
adrenocortical differentiation (51). Dlk1 is co-expressed with Shh
in the outer zU of the rat (Figure 7) (12). Soluble DLK1, like SHH,
modulates Gli1 expression in nearby capsule cells. In addition to
being co-expressed, Dlk1 and Shh are coordinately regulated (12).
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Both genes are downregulated in the adrenals of mice fed a low
Na+ diet. Conversely, Dlk1 and Shh are upregulated in the adrenals
of mice treated with captopril. These findings suggest that DLK1
and SHH may act together to fine tune the activation of signal
receiving cells in the adrenal capsule of the rat. The expression
pattern of Dlk1 differs between rats and mice; in mice Dlk1 is
expressed in the adrenal capsule rather than the underlying cor-
tex. Nevertheless, indirect evidence suggests that in mice, as in
FIGURE 7 | SHH and DLK1 are co-expressed in the outer zU of the rat
adrenal cortex and may act in concert to regulate stem/progenitor
cells in the adrenal capsule. Abbreviations: cap, capsule; DLK1, delta-like
homolog-1; med, medulla; SHH, sonic hedgehog; X, X-zone; zF, zona
fasciculata; zG, zona glomerulosa; zU, undifferentiated zone.
rats, DLK1 may negatively regulate the differentiation of GLI1+
capsular progenitor cells (43).
FIBROBLAST GROWTH FACTOR PATHWAY
Mouse genetic studies have implicated the FGF signaling path-
way in adrenocortical development and maintenance [reviewed in
Ref. (2, 43)]. The FGF family comprises a large group of extra-
cellular ligands that signal through a family of tyrosine kinase
receptors, the FGF receptors (FGFRs). In mammals, the FGFR
family consists of four genes, FGFR1-4, which undergo alternative
splicing to generate an array of receptors that differ in ligand affini-
ties (52). In the presence of heparin, FGFs bind to their cognate
receptors, promoting receptor dimerization and autophosphory-
lation. This in turn stimulates downstream signaling pathways,
including the phosphatidylinositol 3-kinase (PI3K), Janus kinase
and signal transducer and activator of transcription (JAK–STAT),
and mitogen-activated protein kinase (MAPK) pathways. FGF sig-
naling is essential for proper patterning of the embryo, and this
pathway participates in stem cell maintenance (53). Factors in the
FGF pathway are expressed in both the adrenal capsule and cortex,
as summarized in Table 4.
WNT/β-CATENIN SIGNALING
β-catenin exists in two pools: a cytoskeletal pool controls the inter-
action of cadherin complexes with adherens junctions, while a
cytoplasmic pool participates in canonical WNT signaling, act-
ing as a co-activator for transcription factors of the TCF/LEF
family [reviewed in Ref. (2)]. Transcriptionally active β-catenin
has been demonstrated in the AGP, the adrenal primordium, and
adrenal subcapsular cells of the fetus and adult (61) (Figure 8).
WNT/β-catenin signaling is thought to maintain the undifferenti-
ated state of adrenocortical stem/progenitor cells (7, 62). Targeted
mutagenesis of β-catenin in SF1+ cells causes late onset adrenal
hypoplasia, presumed to be the result of stem/progenitor cell pool
Table 4 | FGF ligands and receptors implicated in adrenocortical cell development and homeostasis.
Protein Location Comments Reference
Ligands FGF1 Cortex This isoform activates FGFR2 IIIb (43)
FGF2 Capsule FGF2, which activates FGFR1 IIIc, acts as a mitogen for adrenocortical cells both in culture
and in gland regeneration experiments and has been shown to bind specifically to cells
from the zG
(43, 54–58)
FGF9 Capsule This isoform activates FGFR1 IIIc (43)
Receptors FGFR1 IIIc Capsule
and cortex
This FGFR isoform is expressed in both capsule and cortex, although its precise role in
adrenocortical development is unknown
(43)
FGFR2 IIIb Cortex Like SHH and β-catenin, this FGFR isoform is expressed in the subcapsular region;
embryos with a global Fgfr2 IIIb deletion have hypoplastic adrenal glands, impaired
steroidogenesis, and thickened adrenal capsules with increased Gli1 expression
(43, 59)
FGFR2 IIIc Cortex Like SHH and β-catenin, this FGFR isoform is expressed in clusters of cells in the
subcapsular region. Deletion of both FGFR2 isoforms in steroidogenic tissues leads to
hypoplastic adrenals
(43, 60)
FGFR3 IIIc Cortex This isoform is expressed in cortex, although its precise role in adrenocortical development
is unknown
(43)
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FIGURE 8 | Immunoperoxidase staining of β-catenin in the adrenal
cortex of a 2-month-old female mouse. Abbreviations: cap, capsule; zF,
zona fasciculata; zG, zona glomerulosa; Bar, 30µm.
depletion (61). On the other hand, constitutive activation of β-
catenin in steroidogenic cells expressing aldo-keto reductase family
1, member B7 (Akr1b7 ) causes abnormal accumulation of undif-
ferentiated cells in the capsule and subcapsule and a concomitant
increase in Shh mRNA expression (40).
Regulation of the WNT/β-catenin pathway is complex and
entails not only a family of WNT ligands but also multiple
receptors, co-receptors, decoy receptors, and other modulators
(Table 5). This complexity allows fine tuning of the response to
morphogen gradients. Stem cell self-renewal mechanisms are fre-
quently co-opted to drive oncogenesis, and WNT signaling is the
pathway most frequently mutated in adrenocortical carcinomas
(63) (Table 5).
In addition to its proposed role in stem cell maintenance and
recruitment, the WNT/β-catenin pathway has been implicated in
tissue patterning in the adult organism. For example, proper zona-
tion of the liver requires restriction of WNT/β-catenin signaling
to hepatocytes near the central vein (64). In an analogous fashion,
restriction of WNT signaling to the periphery of the adrenal cortex
is thought to direct zonation in this tissue. Constitutive activation
of β-catenin signaling in the mouse zF using Akr1b7-cre triggers
the ectopic expression of the zG marker Cyp11b2 and increased
production of aldosterone (40, 65). Moreover, studies have shown
that β-catenin directly regulates the expression of genes critical for
zG function, including At1r and Cyp11b2 (66).
Recent studies have shown that proper differentiation of
zF cells requires suppression of WNT/β-catenin signaling (67).
In vitro treatment of a zF cell line (ATCL7) with a chemical
inducer of canonical WNT signaling (BIO) resulted in down-
regulation of genes essential for zF function, including Mc2r,
Cyp11a1, and Cyp11b1 (68). Promoter analyses suggested that
the molecular basis for this repression may involve the displace-
ment of SF1 from steroidogenic gene promoters by β-catenin (68).
These experiments also identified CCDC80 as a novel secreted
inhibitor of zF steroidogenesis. Collectively these studies suggest
that coordinated regulation of WNT/β-catenin signaling is criti-
cal for adrenocortical patterning; WNT/β-catenin signaling must
be active for zG determination and must be extinguished for zF
determination.
OTHER SIGNALING PATHWAYS IMPLICATED IN
ADRENOCORTICAL GROWTH AND REMODELING
Adrenocortical growth and homeostasis are controlled by a diverse
array of endocrine/paracrine factors, including ACTH, Ang II, and
insulin-related growth factors (IGFs) (15, 24). Hormones tradi-
tionally associated with reproductive function, including luteiniz-
ing hormone (LH), activin, inhibin, and prolactin, also influence
the differentiation and function of adrenocortical cells [reviewed
in Ref. (15)].
cAMP SIGNALING
Many of the hormones that regulate adrenocortical cell prolifer-
ation bind to G-protein coupled receptors on the surface of cells
[reviewed in Ref. (38)]. Activation of these receptors stimulates
adenylate cyclase, resulting in cAMP production. cAMP binds to
the regulatory subunits of PKA, allowing the catalytic subunits
of protein kinase A (PKA) to phosphorylate downstream effec-
tors, including transcription factors that enhance expression of
steroidogenic genes (38).
Inactivating mutations in the protein kinase-A regulatory
subunit gene (PRKAR1A) lead to excessive cAMP production.
Such mutations cause Carney complex, a syndrome associated
with pituitary-independent Cushing syndrome and adrenocortical
neoplasia. Conditional deletion of Prkar1a in the adrenal cortex
of mice (using Akr1b7-cre) leads to disrupted stem/progenitor cell
differentiation, excess cell proliferation, and impaired apoptosis
in the adrenal cortex (37). This resistance to apoptosis is medi-
ated in part by crosstalk between the PKA and mammalian target
of rapamycin (mTOR) pathways (39). As these mice age, a new
zone composed of cells that express Cyp17a1 and secrete cortisol
appears in the inner aspect of the cortex. This ectopic X-like zone
is thought to arise from normally dormant stem/progenitor cells
in the juxtamedullary region (37, 38). These studies and others
(38) indicate that normal adrenocortical cell differentiation and
proliferation require proper regulation of PKA activity.
IGF SIGNALING
This pathway has been implicated in growth and differentiation of
adrenocortical cells. The IGF family consists of two ligands, IGF1
and IGF2, which bind to the receptor tyrosine kinase IGF1R and
promote mitosis/survival via signaling through the MAPK and
PI3K pathways (76, 77). IGF1 and IGF2 are expressed at compa-
rable levels in the adult adrenal cortex, whereas IGF2 is highly
and preferentially expressed in the fetal adrenal cortex. IGF1R
is enriched in the subcapsular region (78). The activity of IGFs
is modulated by a family of six IGF-binding proteins (IGFBPs),
which can bind and either stimulate or inhibit the activity of
IGFs (76).
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Table 5 | Factors implicated inWNT/β-catenin signaling in the adrenal cortex.
Factor Function Adrenocortical phenotypes Reference
WNT4 Ligand that activates signaling Wnt4-/- mice have impaired zG differentiation and
decreased aldosterone production
(69)
Frizzled (FZD) Receptor for WNTs (70)
LDL receptor-related proteins
5 and 6 (LRP5/6)
Co-receptors for WNTs (44)
R-spondin-3 (RSPO3) Ligand that potentiates WNT signaling (71)
Leucine-rich repeat containing
G protein-coupled receptor
5 (LGR5)
Receptor for RSPO3; inhibits the activity
of ZNRF3
(72)
Zinc and ring finger 3 (ZNRF3) E3 ubiquitin ligase that inhibits signaling
by promoting the degradation of FZD/LRP
Somatic mutations in ZNRF3 are common in human
adrenocortical carcinomas
(73)
Secreted frizzled related
proteins (SFRP1/2)
Decoy receptors that inhibit signaling by
sequestering WNT ligands away from
activating receptors
The Sfrp1 locus has been linked to GDX-induced
adrenocortical neoplasia in the mouse; decreased
expression of SFRP2 is associated with
aldosterone-producing adenoma development
(66, 74)
Dickkopf-3 (DKK3) Inhibits signaling by interacting with LRPs Dkk3 expression is greater in the zG than in other
zones. Genetic studies indicate that Dkk3 regulates
aldosterone biosynthesis
(70, 75)
Kringle containing
transmembrane protein
1 (KREMEN1)
Inhibits signaling by binding DKK3 and
LRPs and inducing internalization of FZD
Somatic mutations in KREMEN1 are common in
human adrenocortical carcinomas
(63)
Mice deficient in both the Igf1r and the insulin receptor (Insr)
genes exhibit adrenal agenesis and male-to-female sex reversal
(79). The AGP of the double knockout mice contains half the
number of SF1+ cells found in wild-type mice. These data indi-
cate that IGF signaling is pivotal for adrenocortical cell specifi-
cation. Additionally, IGFs have been shown to enhance basal and
ACTH-induced steroidogenesis in fetal and adult adrenocortical
cells (80).
TRANSFORMING GROWTH FACTOR β SIGNALING
The Transforming growth factor β (TGF-β) signaling pathway
has been implicated in the maintenance and differentiation of
stem/progenitor cells (81). The TGF-β superfamily consists of
a diverse array of ligands. Two members of this family, activin
and inhibin, are expressed in the fetal and adult adrenal cortex,
and have been shown to regulate the growth, function, and sur-
vival of adrenocortical cells. Activin signaling is mediated by type
I and type II receptors, which are integral membrane receptor
serine/threonine kinases. Intracellular SMAD proteins transduce
signals from these receptors to the nucleus (81). Activin has been
shown to inhibit adrenocortical cell growth, enhance apoptosis of
X-zone cells, and modulate steroidogenesis (23, 82, 83). By bind-
ing beta-glycan and ActRIA, inhibin blocks activin binding to the
type II receptor and subsequent recruitment of the signaling type
I receptor (83).
Following GDX, ovarian-like tissue accumulates in the adrenal
cortex of Inha-/- mice in an LH dependent manner (23, 84, 85). The
loss of Inha results in constitutive TGF-β2 activation in adreno-
cortical progenitor cells, with subsequent expansion of cells that
express Gata4 and other gonadal-like markers. Thus, Inha impacts
cell fate decisions (adrenal vs. gonadal) in adrenal cortex.
LH SIGNALING
This glycoprotein hormone is composed of a common
gonadotropin α-subunit and hormone-specific β-subunit. LH is
secreted from the pituitary in response to gonadotropin releas-
ing hormone (GnRH). LH binds to G-protein–coupled surface
receptor, LHCGR, present on gonadal steroidogenic cells and acti-
vates downstream signals, including the cAMP/PKA, MAPK, and
PI3K pathways (15). This in turn leads to enhanced expression of
steroidogenic enzyme genes, resulting in increased production of
sex steroids. Activation of LHCGR also has pleiotropic effects on
cell growth and differentiation.
Cells in the adrenal glands express LHCGR and can respond to
surges in LH, as evidenced by the phenomenon of GDX-induced
adrenocortical neoplasia (71). Following GDX, gonadal-like neo-
plasms accumulate in the subcapsular region of the adrenal cortex
of certain strains of mice. This phenomenon is thought to reflect
LH-induced metaplasia of stem/progenitor cells in the adrenal
cortex, although the term “neoplasia” is used more often than
“metaplasia” to describe the process, because with time these
lesions can evolve into frank adenomas or carcinomas. The neo-
plastic cells express gonadal-like markers (e.g., Lhcgr, Gata4, and
Cyp17a1) and secrete sex steroids (86). This phenomenon occurs
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in other species such as ferrets and goats [reviewed in Ref. (71)].
Moreover, adrenocortical tumors with histologic features resem-
bling luteinized ovarian stroma (“thecal metaplasia”) have been
reported, albeit rarely, in postmenopausal women and men with
acquired testicular atrophy. Genetic and pharmacologic experi-
ments using mice or ferrets support the premise that LH has a
central role in GDX-induced adrenocortical neoplasia [reviewed
in Ref. (15, 71)]. The formation of ectopic gonadal-like tissue
in the adrenal gland can be viewed as an extreme example of
adrenocortical remodeling in response to GDX (13, 25).
TRANSCRIPTION FACTORS IMPLICATED IN RENEWAL AND
REMODELING
SF1
SF1 is a master regulator of adrenocortical development and the
prototype of steroidogenic transcription factors. SF1 regulates a
wide array of genes required for steroidogenic cell function (87,
88). Traditionally, SF1 has been classified as an orphan nuclear
receptor, but recent studies have shown that certain phospho-
lipids and sphingolipids bind and regulate this transcription factor
[reviewed in Ref. (89)]. For example, the activity of SF1 can be
modulated by phosphorylation of the 3-position of the inositol
head group of phosphatidylinositol-4,5-bisphosphate PI(4,5)P2
while this phospholipid is bound to SF1 (90). Thus, it is hypoth-
esized that multiple bioactive lipids function as ligands for SF1
and differentially regulate SF1 activity in a context-dependent
manner (89).
Sf1-/- mice exhibit degeneration of the AGP due to apoptosis,
which results in agenesis of both the adrenal glands and gonads
(91). Similarly, targeted mutagenesis of transcription factors that
activate Sf1 expression, such as Wt1, Pbx1, and Cited, severely
impairs adrenal gland development [reviewed in Ref. (25, 26, 92)].
Sf1± mice have small adrenal glands, reduced corticosterone pro-
duction in response to stress, and impaired compensatory growth
response following unilateral adrenalectomy (91, 93). Individuals
with mutations in the DNA-binding domain of SF1 exhibit pri-
mary adrenal failure and gonadal dysgenesis. In addition to regu-
lating steroidogenesis, this transcription factor has been implicated
in the control of other fundamental cellular processes including
glycolysis (87, 88).
Mice harboring multiple copies of Sf1, mimicking the amplifi-
cation of Sf1 seen in childhood adrenocortical carcinoma (94, 95),
develop adrenocortical neoplasms that express gonadal-like mark-
ers. This suggests that SF1 can influence cell fate determination.
Intriguingly, genetic ablation of the SF1 target gene Vnn1, encod-
ing the gonadal-like marker Vanin-1, has been shown to reduce
the severity of neoplastic lesions in the Sf1 transgenic mice (96).
Similarly, mice in which the endogenous Sf1 gene of the mouse
has been replaced with a mutant lacking a key SUMOylation site
exhibit abnormal cell fate specification in steroidogenic tissues,
including ectopic expression of gonadal markers (97). The mutant
mice also exhibit persistence of the X-zone (97).
DOSAGE-SENSITIVE SEX REVERSAL, ADRENAL HYPOPLASIA CRITICAL
REGION ON CHROMOSOME X (DAX1)
The activity of SF1 is modulated by Dax1 (also called Nr0b1),
an X-linked gene that encodes a repressor of steroidogenic
gene expression (98). In response to ACTH, SF1-positive sub-
capsular progenitors downregulate Dax1 and differentiate into
adrenocorticoid-producing cells. DAX1 deficiency in humans and
mice leads to excessive differentiation of subcapsular progenitors
and eventual depletion of the stem/progenitor cell compartment
(99, 100). Cytomegaly, a hallmark of adrenal dysfunction asso-
ciated with Dax1 deficiency (98, 99, 101), is thought to be a
compensatory response to a reduced number of cortical cells or to
progenitor cell exhaustion (100).
TCF21
TCF21 (also known as POD1) is a basic helix-loop-helix transcrip-
tion factor functions as a repressor of Sf1 (102). Tcf21 is expressed
in the adrenal capsule of adult mice (103), and adrenal glands from
Tcf21-/- mice exhibit ectopic expression of Sf1 in the capsule (103).
As mentioned previously, some capsule cells are derived from prog-
enitors in the fetal adrenal cortex, and it has been proposed that
TCF21 downregulates Sf1 expression in these cells upon recruit-
ment into the capsule (27). Lineage tracing studies have shown
that TCF21+ capsular cells give rise to non-steroidogenic stro-
mal cells in the adrenal cortex, but not to steroidogenic cells (27).
Collectively these studies suggest that TCF21+ cells in the adrenal
capsule participate in adrenocortical homeostasis.
WT1
Fate mapping studies of WT1+ cells have identified long-lived
progenitor population in the adrenal capsule characterized by
expression of Wt1 and Gata4, markers of the AGP (25, 104). Under
basal conditions these AGP-like cells give rise to normal adrenocor-
tical cells (Figure 9). GDX activates these WT1+ progenitors and
drives their differentiation into gonadal-like steroidogenic tissue.
Hence, WT1+ capsular cells represent a reserve stem/progenitor
cell population with AGP-like features that can be mobilized in
response to extreme physiological demand (i.e., the hormonal
changes associated with GDX).
In the mouse embryo Wt1 repression is necessary for proper
expression of Sf1 and differentiation of stem/progenitor cells into
adrenocortical cells (25, 104). Ectopic expression of a transcrip-
tionally active isoform of WT1 in SF1+ progenitors causes adreno-
cortical hypoplasia, increased expression of Gata4, Gli1, and Tcf21,
and contraction of the X-zone. WT1 directly regulates the expres-
sion of Gli1 in adrenal tissue suggesting that ectopic expression
of Wt1 prevents differentiation into SF1+ adrenocortical steroido-
genic cells by maintaining cells in a GLI1+ progenitor state.
GATA BINDING PROTEIN-6 (GATA6)
This transcription factor is expressed in the adrenal cortex of the
fetal mouse (105). Postnatally, adrenal expression of Gata6 is lim-
ited to capsular and subcapsular cells (106). Targeted deletion of
Gata6 in SF1+ cells results in a pleiotropic adrenal phenotype
that includes a thin adrenal cortex, cytomegaly, blunted corticoid
production, ectopic chromaffin cells, and aberrant expression of
gonadal-like markers (106). Thus, GATA6 is thought to limit the
differentiation of adrenal stem/progenitor cells into gonadal-like
cells.
Gata6 mutant mice also exhibit abnormal adrenocortical zona-
tion: virgin females lack an X-zone, and castrate males lack a
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secondary X-zone (Figures 10A,B) (106). Gata6 is not expressed
in the X-zone of postnatal wild-type mice, arguing that the effect
of Gata6 ablation on X-zone development is either a non-cell
autonomous phenomenon or that it occurs in fetal adrenal cells
that co-express Gata6 and Sf1-cre (106). Recently, Sergei Tevosian’s
laboratory reported that Gata4/Gata6 double knockout mice gen-
erated with Sf1-cre exhibit severe adrenal hypoplasia; female dou-
ble knockout mice die from adrenocortical insufficiency, whereas
their male counterparts survive due to heterotopic glucocorticoid
production by cells in the testes (107).
Circumstantial evidence from other organ systems suggests that
GATA6 may modulate developmental signaling pathways in the
adrenal cortex. In epithelial cells of the lung and intestine, GATA6
interacts with the WNT/β-catenin and TGF-β signaling pathways
FIGURE 9 |WT1 marks a population of AGP-like progenitors within the
adrenal capsule of the mouse. Under basal conditons, AGP-like cells give
rise to normal steroidogenic cells in the cortex, as evidenced by lineage
tracing analysis with a GFP reporter. Gonadectomy (GDX) triggers the
differentiation of AGP-like cells into wedges of gonadal-like steroidogenic
tissue. Secretion of sex steroids and other hormones by the ectopic
gonadal tissue causes regression of the subjacent X-zone. Abbreviations:
cap, capsule; med, medulla; X, X-zone; zF, zona fasciculata; zG, zona
glomerulosa.
to regulate the balance between stem/progenitor cell expansion
and differentiation (108–113). Hindlimb buds express Gata6 in
an anterior-posterior gradient, and conditional deletion of Gata6
in limb bud mesenchyme of mice leads to ectopic expression of Shh
and its target gene Gli1. The mutant mice develop hindlimb preax-
ial polydactyly. Conversely, enforced expression of Gata6 in the
limb bud represses expression of Shh and results in hypomorphic
limbs. In an analogous fashion, GATA6 may repress transcription
of Shh and Gli1 in the adrenal cortex. Consistent with this notion,
Gli1 has been shown to be upregulated in the adrenal glands of
gonadectomized Gata6flox/flox;Sf1-cre mice (106).
SUMMARY AND PERSPECTIVES
The continual remodeling of the zones of the adrenal cortex
requires the precise control of cell growth and differentiation.
The process involves distinct pools of stem/progenitor cells in the
capsule, subcapsule, and elsewhere. Direct lineage conversion of
mature steroidogenic cells is also integral to adrenocortical zona-
tion and remodeling. The pathways involved are complex and
redundant so as to fulfill the offsetting goals of organ homeostasis
and stress adaptation. Disruption of these pathways can lead to
neoplasia.
Although much has been learned about the regulation of
adrenocortical homeostasis and regeneration, there are still many
unanswered questions. It has proven difficult to isolate and char-
acterize adrenocortical stem cell populations, and we do not know
how these populations vary with age. Nor do we understand the
relative contributions of the hedgehog, DLK1, FGF, and WNT/β-
catenin signaling pathways to adrenocortical differentiation, or
how these pathways interface with classic endocrine signaling sys-
tems, such as the RAAS and the HPA axis. The positional cues that
mediate differentiation during centripetal (or centrifugal) migra-
tion also remain enigmatic. In other epithelial organs (e.g., liver,
intestine, and lung) the development of in vitro systems, such as
organoid cultures and induced pluripotent stem cell models, has
helped to elucidate the regulation of differentiation (114). To date,
there has been little progress in the development of in vitro models
to study adrenocortical differentiation. Hopefully, such techniques
will emerge in the coming years and help drive the field forward.
FIGURE 10 | GATA6 is required for formation of a secondary X-zone.
(A,B) 3-week-old Sf1-cre; Gata6flox/+ or Sf1-cre; Gata6flox/flox mice were
orchiectomized. Adrenal tissue was harvested 1 month later, and paraffin
sections were stained with H&E. Note the absence of a secondary X-zone in
the mutant mice. The asterisk highlights gonadal-like cells in the subcapsular
region. Bar, 50µm.
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